cagrilintide side effects reddit Discovery of BGM1812, a Novel Dual Amylin and Calcitonin Receptor Agonist for Obesity Treatment Amycretin — a novel obesity
Amycretin a novel obesity treatment that targets both GLP 1 and amylin receptors has shown early success in phase 1 testing and will be advanced into phase 3 testing. http: ms.spr.ly 6185SLoJD NN1213 A Potent, Long Acting, and Selective Analog of Human Amylin Journal of Medicinal Chemistry Zepbound beats CagriSema in head to head trial : r Zepbound The role of amylin, a gutbrain axis hormone, in metabolic and neurological disorders Muhammad 2025 FASEB BioAdvances Wiley Online Library
Pay in 4 interest-free payments of $5.50 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6


